Literature DB >> 15227674

Development of biodegradable poly(propylene fumarate)/poly(lactic-co-glycolic acid) blend microspheres. II. Controlled drug release and microsphere degradation.

Diederik H R Kempen1, Lichun Lu, Xun Zhu, Choll Kim, Esmaiel Jabbari, Wouter J A Dhert, Bradford L Currier, Michael J Yaszemski.   

Abstract

This article describes the effects of six processing parameters on the release kinetics of a model drug Texas red dextran (TRD) from poly(propylene fumarate)/poly(lactic-co-glycolic acid) (PPF/PLGA) blend microspheres as well as the degradation of these microspheres. The microspheres were fabricated using a double emulsion-solvent extraction technique in which the following six parameters were varied: PPF/PLGA ratio, polymer viscosity, vortex speed during emulsification, amount of internal aqueous phase, use of poly(vinyl alcohol) in the internal aqueous phase, and poly(vinyl alcohol) concentration in the external aqueous phase. We have previously characterized these microspheres in terms of microsphere morphology, size distribution, and TRD entrapment efficiency. In this work, the TRD release profiles in phosphate-buffered saline were determined and all formulations showed an initial burst release in the first 2 days followed by a decreased sustained release over a 38-day period. The initial burst release varied from 5.1 (+/-1.1) to 67.7 (+/-3.4)% of the entrapped TRD, and was affected most by the viscosity of the polymer solution used for microsphere fabrication. The sustained release between day 2 and day 38 ranged from 7.9 (+/-0.8) to 27.2 (+/-3.1)% of the entrapped TRD. During 11 weeks of in vitro degradation, the mass of the microspheres remained relatively constant for the first 3 weeks after which it decreased dramatically, whereas the molecular weight of the polymers decreased immediately upon placement in phosphate-buffered saline. Increasing the PPF content in the PPF/PLGA blend resulted in slower microsphere degradation. Overall, this study provides further understanding of the effects of various processing parameters on the release kinetics from PPF/PLGA blend microspheres thus allowing modulation of drug release to achieve a wide spectrum of release profiles. Copyright 2004 Wiley Periodicals, Inc. J Biomed Mater Res 70A: 293-302, 2004

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15227674     DOI: 10.1002/jbm.a.30080

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  6 in total

1.  Controlled release of vascular endothelial growth factor using poly-lactic-co-glycolic acid microspheres: in vitro characterization and application in polycaprolactone fumarate nerve conduits.

Authors:  Jing Rui; Mahrokh Dadsetan; M Brett Runge; Robert J Spinner; Michael J Yaszemski; Anthony J Windebank; Huan Wang
Journal:  Acta Biomater       Date:  2011-10-07       Impact factor: 8.947

2.  Fibroblast growth factor-2 and vascular endothelial growth factor mediated augmentation of angiogenesis and bone formation in vascularized bone allotransplants.

Authors:  Mikko Larsen; Wouter F Willems; Michael Pelzer; Patricia F Friedrich; Mahrokh Dadsetan; Allen T Bishop
Journal:  Microsurgery       Date:  2014-01-03       Impact factor: 2.425

3.  Augmentation of surgical angiogenesis in vascularized bone allotransplants with host-derived a/v bundle implantation, fibroblast growth factor-2, and vascular endothelial growth factor administration.

Authors:  Mikko Larsen; Wouter F Willems; Michael Pelzer; Patricia F Friedrich; Michael J Yaszemski; Allen T Bishop
Journal:  J Orthop Res       Date:  2010-08       Impact factor: 3.494

4.  Novel polymer-based system for intrauterine delivery of everolimus for anti-cancer applications.

Authors:  Brenda Melendez; Sarita Shah; Yunyun Jiang; Joseph Dottino; Emma Watson; Hannah Pearce; Mikayla Borthwick; Rosemarie E Schmandt; Qian Zhang; Kayleah Cumpian; Joseph Celestino; Bryan Fellman; Ying Yuan; Karen H Lu; Antonios G Mikos; Melinda S Yates
Journal:  J Control Release       Date:  2021-10-12       Impact factor: 9.776

5.  Effect of rhBMP-2 and VEGF in a vascularized bone allotransplant experimental model based on surgical neoangiogenesis.

Authors:  Tiago Mattar; Patricia F Friedrich; Allen T Bishop
Journal:  J Orthop Res       Date:  2012-11-28       Impact factor: 3.494

6.  A Long-Acting BMP-2 Release System Based on Poly(3-hydroxybutyrate) Nanoparticles Modified by Amphiphilic Phospholipid for Osteogenic Differentiation.

Authors:  Xiaochun Peng; Yunsu Chen; Yamin Li; Yiming Wang; Xianlong Zhang
Journal:  Biomed Res Int       Date:  2016-06-09       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.